New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GERN;HK;HWD;ISRG;MRO;ONTY;THLD;TROX;ZIOP;STRZA;XWES;NFLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
September 25, 2014
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
September 24, 2014
14:00 EDTISRGIntuitive Surgical volatility at low on tight three-month range
Subscribe for More Information
12:29 EDTNFLX20th Century Fox signs TV deal with Canadian Shomi, The Hollywood Reporter says
Subscribe for More Information
12:14 EDTNFLXNetflix responds to Comcast's extortion claims, Variety reports
Subscribe for More Information
09:17 EDTNFLXComcast accuses TWC deal opponents of extortion, Re/code reports
Subscribe for More Information
09:05 EDTSTRZAOn The Fly: Pre-market Movers
Subscribe for More Information
07:36 EDTISRGIntuitive Surgical stapler issue unlikely to impact results, says JPMorgan
Subscribe for More Information
06:40 EDTSTRZAStarz volatility expected to move, hires investment bank to explore sale report
Subscribe for More Information
05:57 EDTSTRZAStarz hires investment bank to explore sale, WSJ reports
Subscribe for More Information
05:51 EDTSTRZAStarz met with 21st Century Fox about takeover, LA Times reports
Starz (STRZA) met with 21st Century Fox (FOXA) on Tuesday to discuss a potential takeover of the cable movie service, Los Angeles Times reports, citing three people familiar with the meeting. No deal may materialize and Fox took the meeting as a courtesy, the paper adds, citing a source. Reference Link
September 23, 2014
10:02 EDTISRGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:48 EDTNFLXNetflix declines providing CRTC subscriber information, Globe and Mail says
Subscribe for More Information
06:17 EDTISRGIntuitive Surgical initiated with a Sector Perform at RBC Capital
Target $523.
05:54 EDTNFLXStocks with implied volatility movement; NFLX AMZN
Subscribe for More Information
September 22, 2014
16:00 EDTNFLXOptions Update; September 22, 2014
iPath S&P 500 VIX Short-Term Futures up 91c to 28.14. Option volume leaders: AAPL TSLA NFLX C TWTR AMZN BP PBR CLF WLT according to Track Data.
09:15 EDTTHLDOn The Fly: Pre-market Movers
HIGHER: Sigma-Aldrich (SIAL), up 34% after Merck KGaA (MKGAY) to acquire the company for $17B... Viasystems (VIAS), up 44% after TTM Technologies (TTMI) acquires the company for $16.46 per share in cash and stock. TTM is up 15.5% after the deal... Clorox (CLX), up 5.4% after the New York Post said the company turned down offer to sell or merge with rival... EMC (EMC), up 2.5% after The Wall Street Journal said the company is considering options that could include merging with a rival and held on-and-off merger talks with Hewlett-Packard (HPQ) for almost a year, though the Journal added that those talks recently ended... Epiq Systems (EPIQ), up 9.9% after P2 Capital confirms 16.9% stake in Epiq and that the company turned down the shareholders' $20 per share takeover offer... Dresser-Rand (DRC), up 2.7% after the company sells to Siemens (SIEGY) for $83 per share or $7.6B... TAT Technologies (TATT), up 6.6% after a division of the company signed a maintenance agreement with Republic Airways (RJET). LOWER: Yahoo (YHOO), down 2.1% after stock was downgraded at Bank of America Merrill Lynch and at Bernstein... InvenSense (INVN), down 2.9% after downgraded at RW Baird... Threshold Pharmaceuticals (THLD), down 5.6% after TH-302 Phase 3 trial events to occur later than expected.
08:07 EDTTHLDThreshold Pharmaceuticals announces TH-302 Phase 3 trial will continue
Threshold Pharmaceuticals announced that the Independent Data Monitoring Committee, or IDMC, has completed the planned interim efficacy and safety analyses of unblinded data for the Company's pivotal Phase 3 clinical trial of TH-302 in combination with doxorubicin versus doxorubicin alone in patients with locally advanced unresectable or metastatic soft tissue sarcoma, or STS. Based on their analyses, which included an assessment of both benefit and risk, the IDMC recommended that the trial should continue as planned to its natural conclusion. Threshold and its partner Merck KGaA, Darmstadt, Germany, have been and will remain blinded to the data from the trial. Based on projections derived from the interim analysis, Threshold is revising its guidance on timing for the number of events required for the primary efficacy analysis. Previously, the company projected the pre-specified number of events would occur around the middle of 2015; the revised projections suggest the requisite events will occur in the latter half of 2015.
07:50 EDTISRGDoctors continue to use morcellators despite FDA warning, J&J halt, WSJ says
Subscribe for More Information
07:47 EDTISRGIntuitive Surgical shipment halt unlikely to have major impact, says Wedbush
Subscribe for More Information
07:45 EDTISRGIntuitive Surgical stapler halt may stop momentum, says Canaccord
Canaccord said Intuitive Surgical's "stop use" notice sent to hospitals regarding its EndoWrist Stapler 45 is a negative and could halt momentum in shares. The firm remains cautious and maintains its Hold rating on Intuitive Surgical given slowing GYN growth, constrained hospital budgets, and the recent change in financial reporting.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use